# US 2008/0306574 A1 · Method for the ablation of cartilage tissue in a knee joint using indocyanine

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0306574 A1
- Document ID: US20080306574A1
- Status: Published application
- Kind: A1
- Application number: 11/760,250
- Filed: 2007-06-08
- Published: 2008-12-11
- Earliest claimed: 2007-06-08
- Assignees: LASERIX sarl
- Inventors: Pierre Ravussin
- Web page: https://patentgrep.com/patent/US20080306574A1

## CPC

- A61N 5/0601: {Apparatus for use inside the body}
- A61B 18/24: with a catheter (A61B18/26, A61B18/28 take precedence)
- A61N 5/062: {Photodynamic therapy, i.e. excitation of an agent}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A method for the ablation of human or animal articular cartilage is disclosed that employs an exogenous absorber, such as a compound having the molecular formula C43H47N2NaO6S2, to coat or color the surface of the articular cartilage. The coated or colored cartilage surface then has an energy absorption peak at a specific wavelength due to the exogenous absorber, which makes it possible to employ a simple and cheap laser diode to generate a pulsed laser beam at the specific wavelength so as to superheat the coated or colored cartilage thereby causing at least partial ablation of cartilage.

## Claims

### Claim 1

A method for the in vivo ablation of human or animal cartilage comprising the steps of:
applying an exogenous absorber to a portion of a surface of cartilage, wherein the exogenous absorber selectively absorbs electromagnetic energy at a first electromagnetic energy spectrum;
generating electromagnetic energy at a second electromagnetic energy spectrum using a laser diode; and
directing the electromagnetic energy generated by the laser diode at the second electromagnetic energy spectrum onto the exogenous absorber applied to the portion of the surface of cartilage so that the exogenous absorber selectively absorbs electromagnetic energy causing at least partial ablation of cartilage.

### Claim 2 (depends on 1)

A method as recited by claim 1, wherein the cartilage is avascular articular cartilage.

### Claim 3 (depends on 2)

A method as recited by claim 2, wherein the articular cartilage is knee joint cartilage.

### Claim 4 (depends on 2)

A method as recited by claim 2, wherein the electromagnetic energy generated by the laser diode is directed through a fluid contained within a joint capsule of a joint before being absorbed by the exogenous absorber, wherein the fluid comprises synovial fluid or an aqueous solution or a mixture of synovial fluid and the aqueous solution.

### Claim 5 (depends on 1)

A method as recited by claim 1, wherein the exogenous absorber is a dye that colors the portion of the surface of the cartilage when applied thereto, and the exogenous absorber comprises a compound having the following formula

### Claim 6 (depends on 2)

A method as recited by claim 2, wherein the exogenous absorber is applied to portion of the surface of articular cartilage in the form of an aqueous solution using at least one trocar inserted into a joint capsule.

### Claim 7 (depends on 6)

A method as recited by claim 6, wherein the aqueous solution is a physiological fluid comprising 0.9% sodium chloride.

### Claim 8 (depends on 6)

A method as recited by claim 6, wherein the aqueous solution is phosphate buffered saline.

### Claim 9 (depends on 1)

A method as recited by claim 1, wherein the exogenous absorber maximally absorbs electromagnetic energy at the first electromagnetic energy spectrum that is equal to, or approximately equal to, the second electromagnetic spectrum.

### Claim 10

A system for ablating cartilage in a human or animal, comprising:
a laser diode that generates a pulsed laser beam at about a first wavelength, wherein each laser pulse generated by the laser diode lasts no more than 10 msec;
an optical conduit connected to transmit the pulsed laser beam generated by the laser diode; and
an exogenous absorber, wherein the exogenous absorber selectively absorbs electromagnetic energy at about a second wavelength so that when the exogenous absorber is applied to a surface of cartilage and is subjected to the pulsed laser beam transmitted by the optical conduit, the exogenous absorber absorbs electromagnetic energy from the pulsed laser beam and effects ablation of at least a portion of the cartilage.

### Claim 11 (depends on 10)

A system as recited in claim 10, wherein the pulsed laser beam generated by the laser diode has a power of greater than 30 W.

### Claim 12 (depends on 10)

A system as recited in claim 10, further comprising a laser device comprising the laser diode connected to a laser diode network.

### Claim 13 (depends on 10)

A system as recited in claim 10, further comprising two trocars, wherein one trocar is an irrigation trocar and the other trocar is an evacuation trocar.

### Claim 14 (depends on 10)

A system as recited in claim 10, wherein the exogenous absorber maximally absorbs electromagnetic energy at the second wavelength that is equal to, or approximately equal to, the first wavelength of the laser diode.

### Claim 15 (depends on 14)

A system as recited in claim 14, wherein the first wavelength and the second wavelength are each at about 785 nm.

### Claim 16 (depends on 14)

A system as recited in claim 14, wherein the exogenous absorber comprises indocyanine green.

### Claim 17 (depends on 14)

A system as recited in claim 14, wherein the exogenous absorber comprises a compound having the following formula

### Claim 18 (depends on 10)

A system as recited in claim 10, wherein the first wavelength is at a wavelength for which a non toxic dye does exist.

### Claim 19 (depends on 10)

A system as recited in claim 10, wherein exogenous absorber comprises a non toxic dye, and the first wavelength is at a wavelength such that an electromagnetic energy absorption peak of the exogenous absorber is at the half wavelength of the laser diode.

### Claim 20 (depends on 10)

A system as recited in claim 10, wherein the first wavelength is at a wavelength such that an electromagnetic energy absorption peak of the exogenous absorber is at the half wavelength of the laser diode.
